Long-term effect on blood pressure of early brief treatment by different antihypertensive agents: A study in the Prague hypertensive rat

Kidney and Blood Pressure Research

Volumn 21, Issue 6, 1998, Pages 445-451

  Heller, Jiřî ^a   Hellerová, Soňa ^a  

^a INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

Author keywords

Early brief treatment of hypertension; Prague hypertensive rat; Renin angiotensin system

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETAXOLOL; LOKREN; LOSARTAN; METIPRANOLOL; NISOLDIPINE; PERINDOPRIL; PRAZOSIN; PROPRANOLOL; UNCLASSIFIED DRUG; VERAPAMIL;

AGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; HEREDITARY HYPERTENSION; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROTEINURIA; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SYSTOLIC BLOOD PRESSURE;

ANALYSIS OF VARIANCE; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; GENETIC PREDISPOSITION TO DISEASE; HYPERTENSION; INDOLES; LOSARTAN; MALE; PERINDOPRIL; RATS; RATS, INBRED STRAINS; TIME FACTORS;

EID: 0032462571     PISSN: 14204096     EISSN: None     Source Type: Journal    
DOI: 10.1159/000025898     Document Type: Article

References (20)

1. Heller J, Hellerová S, Dobesova Z, Kunes J, Zicha J: The Prague hypertensive rat - A new model of genetic hypertension. Clin Exp Hypertens 1993;15:807-818.
2. Weiss L, Lundgren Y, Folkow B: Effects of prolonged treatment with adrenergic receptor antagonists on blood pressure, cardiovascular design and reactivity in spontaneously hypertensive rats. Acta Physiol Scand 1974;91:447-457.
3. Gumulka WS, Zalewska-Rutczynska Z: The effect of labetalol and propranolol on the development of hypertension in spontaneously hypertensive rats. Acta Physiol Pol 1984;35: 41-46.
4. Rizzoni D, Castellano M, Porteri E, Bettoni G, Muiesan ML, Rosei EA: Delayed development of hypertension after short-term nitrendipine treatment. Hypertension 1994;24: 131-139.
5. Lundie MJ, Friberg P, Kline RL, Adams MA: Long-term inhibition of the renin-angiotensin system in genetic hypertension: Analysis of the impact on blood pressure and cardiovascular structural changes. J Hypertens 1997;15: 339-348.
6. Mulvany MJ, Persson AEG, Andresen J: No persistent effect of angiotensin-converting enzyme inhibitor treatment in Milan hypertensive rats despite regression of vascular structure. J Hypertens 1991;9:589-593.
7. Yamori Y, Tarazi RC, Ooshima A: Effect of beta-receptor-blocking agents on cardiovascular structural changes in spontaneous and noradrenaline-induced hypertension in rats. Clin Sci 1980;59:457S-460S.
8. Giudicelli JF, Freslon JL, Glasson S, Richer C: Captopril and hypertension development in SHR. Clin Exp Hypertens 1980;2:1083-1096.
9. Weissinger J: Propranolol can inhibit the development of hypertension in SHR. Clin Exp Hypertens A 1984;6:1169-1177.
10. Christensen KL, Jespersen LT, Mulvany MJ: Development of blood pressure in spontaneously hypertensive rats after withdrawal of long-term treatment related to vascular structure. J Hypertens 1989;80:533-543.
11. Smeda JS, Lee RMKW, Forrest JB: Prenatal and postnatal hydralazine treatment does not prevent renal vessel wall thickening in SHR despite the absence of hypertension. Circ Res 1988;63:534-542.
12. Traub O, Webb RC: Angiotensin-converting enzyme inhibition during development alters calcium regulation in adult hypertensive rats. J Pharmacol Exp Ther 1993;267:1503-1508.
13. Smid SD, Frewin DB, Head RJ: A potential dissociation between the level of maximal contraction in the mesenteric vascular bed and blood pressure in the spontaneously hypertensive rat. Abstr 15th Sci Meet IHS, 1994, p 32.
14. Smid SD, Frewin DB, Wyatt CL, Head RJ: Functional tolerance to alpha-adrenergic receptor blockade in the spontaneously hypertensive rat highlights the multifunctional role of vascular angiotensin II in the development of hypertension. J Vasc Res 1995;32:247-253.
15. Freslon JL, Giudicelli JF: Compared myocardial and vascular effects of captopril and dihydralazine during hypertension development in spontaneously hypertensive rats. Br J Pharmacol 1983;80:533-543.
16. Remuzzi A, Malanchini B, Battaglia C, Bertani T, Remuzzi G: Comparison of the effects of angiotensin-converting enzyme inhibition and angiotensin II receptor blockade on the evolution of spontaneous glomerular injury in male WF/Ztm rats. Exp Nephrol 1996;4:19-25.
17. Adams MA, Bobik A, Korner PI: Enalapril can prevent vascular amplifier development in spontaneously hypertensive rats. Hypertension 1990;16:252-260.
18. Friberg P, Sundelin B, Bohman SO, Bobik A, Nilsson H, Wickman A, Gustafsson H, Petersen J, Adams MA: Renin-angiotensin system in neonatal rats - Induction of a renal abnormality in response to ACE inhibition or angiotensin-II antagonism. Kidney Int 1994; 45:485-492.
19. Harrap SB, Vandermerwe WM, Griffin SA, Macpherson F, Lever AF: Brief angiotensin-converting enzyme treatment in young spontaneously hypertensive rats reduces blood pressure long-term. Hypertension 1990;16:603-614.
20. Campbell DJ, Duncan AM, Kladis A, Harrap SB: Converting enzyme inhibition and its withdrawal in spontaneously hypertensive rats. J Cardiovasc Pharmacol 1995;26:426-436.